News

Terry Van Dyke, Ph.D. Director, NCI Center for Advanced Preclinical Research

Scientists at NCI and Frederick National Laboratory for Cancer Research (FNLCR) are partnering with the Lustgarten Foundation to test whether a vitamin D derivative will make a difference when combined with a conventional anticancer drug in treating tumors of the pancreas.

Pages